Purpose of Review

Surgeons have played a significant role in the current opioid epidemic through overprescribing practices in the postoperative setting. However, contemporary efforts have helped to decrease opioid excess, particularly in the field of urology. Minimally invasive surgery offers a unique avenue to address overuse of narcotics in the postoperative period given its emphasis on enhanced recovery.

Recent Findings

Historically, the majority of the literature characterizing postoperative opioid use and its reduction has focused on non-urological surgery. However, recent studies have shown that patients undergoing urologic procedures are prescribed opioids in a similar manner as patients in other surgical specialties. Reduction strategies have been implemented through the use of regional anesthesia, enhanced recovery after surgery pathways, and the development of procedure-specific opioid prescription recommendations.

Summary

Patients undergoing urologic surgery experience the same risk of opioid misuse and abuse as patients undergoing other types of surgery. However, the wide use of minimally invasive urological surgeries including robotic surgery offers a unique opportunity to reduce postoperative opioid use through multimodal and interdisciplinary protocols and standardizing guidelines.

中文翻译：

---

减少内科程序后的阿片类药物使用。

审查目的

通过在术后环境中过度开处方，外科医生在当前的阿片类药物流行中发挥了重要作用。然而，当代的努力已经帮助减少了阿片类药物的过量，特别是在泌尿科领域。微创手术为强调麻醉剂的恢复提供了独特的途径，可解决术后麻醉药的过度使用。

最近的发现

从历史上看，大多数描述术后使用阿片类药物及其减少的文献都集中在非泌尿外科手术上。然而，最近的研究表明，接受泌尿外科手术的患者与其他外科专科患者的处方阿片类药物相似。减少策略已通过使用区域麻醉，提高手术路径后的恢复率以及制定针对特定过程的阿片类药物处方建议来实施。

概要

进行泌尿外科手术的患者与接受其他类型的手术的患者一样，会遭受阿片类药物滥用和滥用的风险。但是，微创泌尿外科手术（包括机器人手术）的广泛使用为通过多模式和跨学科的方案以及标准化指南减少术后阿片类药物的使用提供了独特的机会。